Skip to main navigation

Home
Overview
News & Events
- Press Releases
- Events and Presentations
Stock Information
- Stock Quote & Chart
- Analyst Coverage
Financials
Governance
IR Resources
- Email Alerts
- Contact IR

Press Releases

Press Releases

Year

May 22, 2023

Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer

May 11, 2023

Athira Pharma Reports First Quarter 2023 Financial Results and Recent Pipeline and Business Updates

May 8, 2023

Athira Pharma to Participate in Upcoming May Investor Conferences

April 25, 2023

Athira Pharma Presents New Clinical and Preclinical Data at the American Academy of Neurology (AAN) 2023 Annual Meeting

April 11, 2023

Athira Pharma Announces Upcoming Presentations at the American Academy of Neurology (AAN) 2023 Annual Meeting

March 28, 2023

Athira Pharma Presents Preclinical Data Supporting Therapeutic Potential of Fosgonimeton for Alzheimer’s and Parkinson’s Diseases at AD/PD™ 2023 International Conference

March 23, 2023

Athira Pharma Reports Full Year 2022 Financial Results and Recent Pipeline and Business Updates

March 8, 2023

Athira Pharma to Present at Upcoming Neuroscience Focused Investor Conferences

March 6, 2023

Athira Pharma to Present Data Supporting Therapeutic Potential of Enhancing HGF/MET Neurotrophic System at Upcoming Scientific Conferences

February 1, 2023

Athira Pharma Announces Publication in Journal of Alzheimer’s Disease Highlighting Need for Novel Alzheimer’s Disease Treatment Approaches and Potential of Enhancing HGF/MET Pathway

Pagination

Current page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Displaying 1 - 10 of 104

SIGN UP FOR EMAIL ALERTS

CONTACT IR

Athira Pharma, Inc.
18706 North Creek Parkway
Suite 104
Bothell, WA 98011

Main line: (866) 725-0930
Local number: (425) 620-8501
info@athira.com

© Athira Pharma, Inc. All rights reserved.